Discontinuation report ALOXI
| Report ID | 12727 |
| Drug Identification Number | 02381710 |
| Brand name | ALOXI |
| Common or Proper name | Aloxi |
| Company Name | KNIGHT THERAPEUTICS INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | PALONOSETRON |
| Strength(s) | 0.25MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 0.25 mg/5 mL |
| ATC code | A04AA |
| ATC description | ANTIEMETICS AND ANTINAUSEANTS |
| Reason for discontinuation | Other (Please describe in comments) |
| Anticipated discontinuation date | 2017-06-13 |
| Actual discontinuation date | 2017-06-13 |
| Remaining supply date | 2017-06-13 |
| Discontinuation status | Reversed |
| Discontinuation decision reversal | Yes |
| Information on remaining supply | |
| Company comments | Purdue Pharma is discontinuing the intravenous solution. IV formulations of other 5HT3s are available in Canada. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3400 DE MAISONNEUVE BLVD W MONTREAL, QUEBEC CANADA H3Z 3B8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2017-09-21 | French | Compare |
| v6 | 2017-09-21 | English | Compare |
| v5 | 2017-09-21 | English | Compare |
| v4 | 2017-06-14 | English | Compare |
| v3 | 2017-06-13 | French | Compare |
| v2 | 2017-06-13 | English | Compare |
| v1 | 2017-06-13 | English | Compare |
Showing 1 to 7 of 7